カテゴリー： QYResearch, 世界

世界の鎌状赤血球症薬市場 2019年

【英語タイトル】Global Sickle Cell Disease Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X15027）・商品コード：DATA909X15027
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、鎌状赤血球症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他に、用途別には、病院、診療所、その他にセグメント区分し、鎌状赤血球症薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・鎌状赤血球症薬の世界市場概要
・鎌状赤血球症薬の製造コスト構成分析
・鎌状赤血球症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・鎌状赤血球症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・鎌状赤血球症薬のセグメント分析（種類別）
（ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他）
・鎌状赤血球症薬のセグメント分析（用途別）
（病院、診療所、その他）
・鎌状赤血球症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Acceleron Pharma Inc、Addmedica SAS、Angiocrine Bioscience Inc、Annexin Pharmaceuticals AB、ArQule Inc、Bio Products Laboratory Ltd、Bioverativ Inc、bluebird bio Inc、Bristol-Myers Squibb Co、Calimmune Inc、CRISPR Therapeutics、CSL Ltd、Daiichi Sankyo Co Ltd、Editas Medicine Inc、Errant Gene Therapeutics LLC、Gamida Cell Ltd、Genethon SA、Gilead Sciences Inc、Global Blood Therapeutics Inc、）
・鎌状赤血球症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Sickle Cell Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Sickle Cell Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sickle Cell Disease Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Sickle Cell Disease Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Sickle Cell Disease Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Acceleron Pharma Inc
Addmedica SAS
Angiocrine Bioscience Inc
Annexin Pharmaceuticals AB
ArQule Inc
Bio Products Laboratory Ltd
Bioverativ Inc
bluebird bio Inc
Bristol-Myers Squibb Co
Calimmune Inc
CRISPR Therapeutics
CSL Ltd
Daiichi Sankyo Co Ltd
Editas Medicine Inc
Errant Gene Therapeutics LLC
Gamida Cell Ltd
Genethon SA
Gilead Sciences Inc
Global Blood Therapeutics Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Sickle Cell Disease Drug
1.1 Definition of Sickle Cell Disease Drug
1.2 Sickle Cell Disease Drug Segment by Type
1.2.1 Global Sickle Cell Disease Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 ARQ-092
1.2.3 BIVV-003
1.2.4 CAL-H
1.2.5 CTX-001
1.2.6 DRX-194
1.2.7 Others
1.3 Sickle Cell Disease Drug Segment by Applications
1.3.1 Global Sickle Cell Disease Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Sickle Cell Disease Drug Overall Market
1.4.1 Global Sickle Cell Disease Drug Revenue (2014-2025)
1.4.2 Global Sickle Cell Disease Drug Production (2014-2025)
1.4.3 North America Sickle Cell Disease Drug Status and Prospect (2014-2025)
1.4.4 Europe Sickle Cell Disease Drug Status and Prospect (2014-2025)
1.4.5 China Sickle Cell Disease Drug Status and Prospect (2014-2025)
1.4.6 Japan Sickle Cell Disease Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Sickle Cell Disease Drug Status and Prospect (2014-2025)
1.4.8 India Sickle Cell Disease Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Sickle Cell Disease Drug
2.3 Manufacturing Process Analysis of Sickle Cell Disease Drug
2.4 Industry Chain Structure of Sickle Cell Disease Drug

3 Development and Manufacturing Plants Analysis of Sickle Cell Disease Drug
3.1 Capacity and Commercial Production Date
3.2 Global Sickle Cell Disease Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Sickle Cell Disease Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Sickle Cell Disease Drug Production and Capacity Analysis
4.2 Sickle Cell Disease Drug Revenue Analysis
4.3 Sickle Cell Disease Drug Price Analysis
4.4 Market Concentration Degree

5 Sickle Cell Disease Drug Regional Market Analysis
5.1 Sickle Cell Disease Drug Production by Regions
5.1.1 Global Sickle Cell Disease Drug Production by Regions
5.1.2 Global Sickle Cell Disease Drug Revenue by Regions
5.2 Sickle Cell Disease Drug Consumption by Regions
5.3 North America Sickle Cell Disease Drug Market Analysis
5.3.1 North America Sickle Cell Disease Drug Production
5.3.2 North America Sickle Cell Disease Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Sickle Cell Disease Drug Import and Export
5.4 Europe Sickle Cell Disease Drug Market Analysis
5.4.1 Europe Sickle Cell Disease Drug Production
5.4.2 Europe Sickle Cell Disease Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Sickle Cell Disease Drug Import and Export
5.5 China Sickle Cell Disease Drug Market Analysis
5.5.1 China Sickle Cell Disease Drug Production
5.5.2 China Sickle Cell Disease Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Sickle Cell Disease Drug Import and Export
5.6 Japan Sickle Cell Disease Drug Market Analysis
5.6.1 Japan Sickle Cell Disease Drug Production
5.6.2 Japan Sickle Cell Disease Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Sickle Cell Disease Drug Import and Export
5.7 Southeast Asia Sickle Cell Disease Drug Market Analysis
5.7.1 Southeast Asia Sickle Cell Disease Drug Production
5.7.2 Southeast Asia Sickle Cell Disease Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Sickle Cell Disease Drug Import and Export
5.8 India Sickle Cell Disease Drug Market Analysis
5.8.1 India Sickle Cell Disease Drug Production
5.8.2 India Sickle Cell Disease Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Sickle Cell Disease Drug Import and Export

6 Sickle Cell Disease Drug Segment Market Analysis (by Type)
6.1 Global Sickle Cell Disease Drug Production by Type
6.2 Global Sickle Cell Disease Drug Revenue by Type
6.3 Sickle Cell Disease Drug Price by Type

7 Sickle Cell Disease Drug Segment Market Analysis (by Application)
7.1 Global Sickle Cell Disease Drug Consumption by Application
7.2 Global Sickle Cell Disease Drug Consumption Market Share by Application (2014-2019)

8 Sickle Cell Disease Drug Major Manufacturers Analysis
8.1 Acceleron Pharma Inc
8.1.1 Acceleron Pharma Inc Sickle Cell Disease Drug Production Sites and Area Served
8.1.2 Acceleron Pharma Inc Product Introduction, Application and Specification
8.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Addmedica SAS
8.2.1 Addmedica SAS Sickle Cell Disease Drug Production Sites and Area Served
8.2.2 Addmedica SAS Product Introduction, Application and Specification
8.2.3 Addmedica SAS Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Angiocrine Bioscience Inc
8.3.1 Angiocrine Bioscience Inc Sickle Cell Disease Drug Production Sites and Area Served
8.3.2 Angiocrine Bioscience Inc Product Introduction, Application and Specification
8.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Annexin Pharmaceuticals AB
8.4.1 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production Sites and Area Served
8.4.2 Annexin Pharmaceuticals AB Product Introduction, Application and Specification
8.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 ArQule Inc
8.5.1 ArQule Inc Sickle Cell Disease Drug Production Sites and Area Served
8.5.2 ArQule Inc Product Introduction, Application and Specification
8.5.3 ArQule Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bio Products Laboratory Ltd
8.6.1 Bio Products Laboratory Ltd Sickle Cell Disease Drug Production Sites and Area Served
8.6.2 Bio Products Laboratory Ltd Product Introduction, Application and Specification
8.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Bioverativ Inc
8.7.1 Bioverativ Inc Sickle Cell Disease Drug Production Sites and Area Served
8.7.2 Bioverativ Inc Product Introduction, Application and Specification
8.7.3 Bioverativ Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 bluebird bio Inc
8.8.1 bluebird bio Inc Sickle Cell Disease Drug Production Sites and Area Served
8.8.2 bluebird bio Inc Product Introduction, Application and Specification
8.8.3 bluebird bio Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Bristol-Myers Squibb Co
8.9.1 Bristol-Myers Squibb Co Sickle Cell Disease Drug Production Sites and Area Served
8.9.2 Bristol-Myers Squibb Co Product Introduction, Application and Specification
8.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Calimmune Inc
8.10.1 Calimmune Inc Sickle Cell Disease Drug Production Sites and Area Served
8.10.2 Calimmune Inc Product Introduction, Application and Specification
8.10.3 Calimmune Inc Sickle Cell Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 CRISPR Therapeutics
8.12 CSL Ltd
8.13 Daiichi Sankyo Co Ltd
8.14 Editas Medicine Inc
8.15 Errant Gene Therapeutics LLC
8.16 Gamida Cell Ltd
8.17 Genethon SA
8.18 Gilead Sciences Inc
8.19 Global Blood Therapeutics Inc

9 Development Trend of Analysis of Sickle Cell Disease Drug Market
9.1 Global Sickle Cell Disease Drug Market Trend Analysis
9.1.1 Global Sickle Cell Disease Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Sickle Cell Disease Drug Regional Market Trend
9.2.1 North America Sickle Cell Disease Drug Forecast 2019-2025
9.2.2 Europe Sickle Cell Disease Drug Forecast 2019-2025
9.2.3 China Sickle Cell Disease Drug Forecast 2019-2025
9.2.4 Japan Sickle Cell Disease Drug Forecast 2019-2025
9.2.5 Southeast Asia Sickle Cell Disease Drug Forecast 2019-2025
9.2.6 India Sickle Cell Disease Drug Forecast 2019-2025
9.3 Sickle Cell Disease Drug Market Trend (Product Type)
9.4 Sickle Cell Disease Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Sickle Cell Disease Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Sickle Cell Disease Drug
Table Global Sickle Cell Disease Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Sickle Cell Disease Drug Production Market Share by Types in 2018
Figure ARQ-092 Product Picture
Figure BIVV-003 Product Picture
Figure CAL-H Product Picture
Figure CTX-001 Product Picture
Figure DRX-194 Product Picture
Figure Others Product Picture
Table Global Sickle Cell Disease Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Sickle Cell Disease Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Sickle Cell Disease Drug Revenue (Million USD) (2014-2025)
Figure Global Sickle Cell Disease Drug Production (K Pcs) (2014-2025)
Figure North America Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Figure Europe Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Figure China Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Figure Japan Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Figure India Sickle Cell Disease Drug Market Size (Million USD) (2014-2025)
Table Sickle Cell Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Sickle Cell Disease Drug in 2018
Figure Manufacturing Process Analysis of Sickle Cell Disease Drug
Figure Industry Chain Structure of Sickle Cell Disease Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Sickle Cell Disease Drug Manufacturing Plants Distribution
Table Sickle Cell Disease Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Sickle Cell Disease Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Sickle Cell Disease Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Sickle Cell Disease Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Sickle Cell Disease Drug Production Share by Manufacturers in 2018
Table Sickle Cell Disease Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Sickle Cell Disease Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Sickle Cell Disease Drug Revenue Share by Manufacturers in 2018
Table Sickle Cell Disease Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Sickle Cell Disease Drug Production by Regions 2014-2019 (K Pcs)
Table Global Sickle Cell Disease Drug Production Market Share by Regions 2014-2019
Figure Global Sickle Cell Disease Drug Production Market Share by Regions in 2018
Table Global Sickle Cell Disease Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Sickle Cell Disease Drug Revenue Market Share by Regions 2014-2019
Figure Global Sickle Cell Disease Drug Revenue Market Share by Regions in 2018
Table Global Sickle Cell Disease Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Sickle Cell Disease Drug Consumption Market Share by Regions 2014-2019
Figure North America Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure China Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure India Sickle Cell Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Sickle Cell Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Sickle Cell Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Sickle Cell Disease Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Sickle Cell Disease Drug Market Share by Application (2014-2019)
Table Acceleron Pharma Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Acceleron Pharma Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Acceleron Pharma Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Acceleron Pharma Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Acceleron Pharma Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Acceleron Pharma Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Acceleron Pharma Inc Sickle Cell Disease Drug Main Business and Markets Served
Table Addmedica SAS Sickle Cell Disease Drug Production Sites and Area Served
Table Addmedica SAS Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Addmedica SAS Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Addmedica SAS Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Addmedica SAS Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Addmedica SAS Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Addmedica SAS Sickle Cell Disease Drug Main Business and Markets Served
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Angiocrine Bioscience Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Main Business and Markets Served
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production Sites and Area Served
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Annexin Pharmaceuticals AB Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Main Business and Markets Served
Table ArQule Inc Sickle Cell Disease Drug Production Sites and Area Served
Table ArQule Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table ArQule Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ArQule Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table ArQule Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure ArQule Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table ArQule Inc Sickle Cell Disease Drug Main Business and Markets Served
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Production Sites and Area Served
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Bio Products Laboratory Ltd Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Main Business and Markets Served
Table Bioverativ Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Bioverativ Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Bioverativ Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bioverativ Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Bioverativ Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Bioverativ Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Bioverativ Inc Sickle Cell Disease Drug Main Business and Markets Served
Table bluebird bio Inc Sickle Cell Disease Drug Production Sites and Area Served
Table bluebird bio Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table bluebird bio Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table bluebird bio Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table bluebird bio Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure bluebird bio Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table bluebird bio Inc Sickle Cell Disease Drug Main Business and Markets Served
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Production Sites and Area Served
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Co Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Main Business and Markets Served
Table Calimmune Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Calimmune Inc Sickle Cell Disease Drug Product Introduction, Application and Specification
Table Calimmune Inc Sickle Cell Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Calimmune Inc Sickle Cell Disease Drug Production Growth Rate (2014-2019)
Table Calimmune Inc Sickle Cell Disease Drug Production Market Share (2014-2019)
Figure Calimmune Inc Sickle Cell Disease Drug Revenue Market Share (2014-2019)
Table Calimmune Inc Sickle Cell Disease Drug Main Business and Markets Served
Table CRISPR Therapeutics Sickle Cell Disease Drug Production Sites and Area Served
Table CSL Ltd Sickle Cell Disease Drug Production Sites and Area Served
Table Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Production Sites and Area Served
Table Editas Medicine Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Errant Gene Therapeutics LLC Sickle Cell Disease Drug Production Sites and Area Served
Table Gamida Cell Ltd Sickle Cell Disease Drug Production Sites and Area Served
Table Genethon SA Sickle Cell Disease Drug Production Sites and Area Served
Table Gilead Sciences Inc Sickle Cell Disease Drug Production Sites and Area Served
Table Global Blood Therapeutics Inc Sickle Cell Disease Drug Production Sites and Area Served
Figure Global Sickle Cell Disease Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Sickle Cell Disease Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Sickle Cell Disease Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Sickle Cell Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Sickle Cell Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Sickle Cell Disease Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Sickle Cell Disease Drug by Application (2019-2025)
Table Sickle Cell Disease Drug Distributors List
Table Sickle Cell Disease Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Acceleron Pharma Inc、Addmedica SAS、Angiocrine Bioscience Inc、Annexin Pharmaceuticals AB、ArQule Inc、Bio Products Laboratory Ltd、Bioverativ Inc、bluebird bio Inc、Bristol-Myers Squibb Co、Calimmune Inc、CRISPR Therapeutics、CSL Ltd、Daiichi Sankyo Co Ltd、Editas Medicine Inc、Errant Gene Therapeutics LLC、Gamida Cell Ltd、Genethon SA、Gilead Sciences Inc、Global Blood Therapeutics Inc、

★調査レポート[世界の鎌状赤血球症薬市場 2019年] (コード：DATA909X15027)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の鎌状赤血球症薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 鎌状赤血球症診断の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101229 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、鎌状赤血球症診断の世界市場について調べ、まとめました。種類別セグメントは、テストサービス、テストキット等、用途別セグメントは、新生児、大人等に区分しました。鎌状赤血球症診断の世界市場概観、企業動向、企業別鎌状赤血球症診断シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・鎌状赤血球症診断の市場概観 ・鎌状赤血球症診断の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・鎌状赤血球症診断の企業別販売動向、市場シェア、市場集中度、競争動向 ・鎌状赤血球症診断の世界市場規模 ・鎌状赤血球症診断の北米市場分析（アメリカ、カナダ、メキシコ等） ・鎌状赤血球症診断のアメリカ市場規模推移 ・鎌状赤血球症診断のカナダ市場規模推移 ・鎌状赤血球症診断のメキシコ市場規模推移 ・鎌状赤血球症診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Sickle Cell Disease Diagnosis market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sickle Cell Disease Diagnosis. Europe also play important...
  • 世界のクローン病薬市場 2019年
    DATA909X06111 / QYResearch / 2019年11月15日 / ※本調査レポートは、クローン病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節薬、抗生物質に、用途別には、寛解の達成（症状の欠如）、寛解の維持（再燃の予防）、小児クローン病にセグメント区分し、クローン病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・クローン病薬の世界市場概要 ・クローン病薬の製造コスト構成分析 ・クローン病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・クローン病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・クローン病薬のセグメント分析（種類別） （アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節薬、抗生物質）...The global Crohn’s Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Crohn’s Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Crohn’s Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Crohn’s Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のデビック病薬市場 2019年
    DATA909X06374 / QYResearch / 2019年11月15日 / ※本調査レポートは、デビック病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グルココルチコイド、免疫グロブリン、その他に、用途別には、病院、診療所、その他にセグメント区分し、デビック病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・デビック病薬の世界市場概要 ・デビック病薬の製造コスト構成分析 ・デビック病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・デビック病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・デビック病薬のセグメント分析（種類別） （グルココルチコイド、免疫グロブリン、その他）...The global Devic's Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Devic's Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Devic's Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Devic's Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆